Professor Chng is the Executive Director of the Singapore Translational Cancer Consortium. He also holds co-current appointments as Director of the National University Cancer Institute of Singapore (NCIS) at the National University Health System, Singapore (NUHS). He is also the Group Director of Research Office at the National University Health System and Vice-Dean of Research at the Yong Loo Lin School of Medicine as well as the Deputy Director and a Senior Principal Investigator at the Cancer Science Institute (CSI), Singapore, National University of Singapore (NUS). Professor Chng is also the Provost’s Chair Professor at the Yong Loo Lin School of Medicine, National University of Singapore.
Professor Lim is the Co-Director of the Singapore Translational Cancer Consortium. His other leadership roles and positions include serving as the Chairman of the Singhealth Central Institutional Review Board, Director of the Clinical Service Academic Clinical Program Oncology, Chairman of the cancer service line development, and Chairman of the Medical Oncology Residency Advisory Committee. Additionally, he is also the current associate Dean for Clinical Education at Duke-NUS Medical School.
Mr Clarence Khoo
Director of Operations & Strategy
Mr Clarence Khoo is the Director of Operations and Strategy with the Singapore Translational Cancer Consortium. A clinical pharmacist by training, he is experienced in clinical development, project management and regulatory affairs, having worked in multinational pharmaceutical companies, hospitals and the Singapore regulatory agency. In the roles in the pharmaceutical industry, he has had responsibilities for the planning and operationalisation of regional as well as global clinical studies (early phase to late phase development programmes and non-interventional studies).